Stress and quality of life in psoriasis: An update

International Journal of Dermatology

Volumn 50, Issue 7, 2011, Pages 783-792

  Basavaraj, Kabbur H ^a   Navya, Mysore Ashok ^a   Rashmi, Ramesh ^a  

^a JSS MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; COMORBIDITY; DISEASE EXACERBATION; DISEASE SEVERITY; EMOTIONAL STRESS; FEEDBACK SYSTEM; HUMAN; MEDITATION; MENTAL STRESS; MORBIDITY; PERCEPTION; PREVALENCE; PSORIASIS; QUALITY OF LIFE; REVIEW; SELF HELP; YOGA;

COMORBIDITY; HUMANS; PSORIASIS; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL;

EID: 79959615784     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2010.04844.x     Document Type: Review

References (103)

1. Root S, Kent G, Al Abadie MSK. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994; 189: 234-237.
2. Picardi A, Abeni D, Melchi CF, et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-991.
3. Richards HL, Fortune DG, Griffiths CE, Main CJ. The contribution of perceptions of stigmatisation to disability in patients with psoriasis. J Psychosom Res 2001; 50: 11-15.
4. Vardy D, Besser A, Amir M, et al. Experiences of stigmatization play a role in mediating the impact of disease severity on quality of life in psoriasis patients. Br J Dermatol 2002; 147: 736-742.
5. De Arruda LH, De Moraes AP. The impact of psoriasis on quality of life. Br J Dermatol 2001; 144: 33-36.
6. Plunkett A, Marks R. A review of the epidemiology of psoriasis vulgaris in the community. Australas J Dermatol 1998; 39: 225-232.
7. Ortonne JP. Recent developments in the understanding of the pathogenesis of psoriasis. Br J Dermatol 1999; 140: 1-7.
8. Koo J, Lee CS. Psycotropic agents. In: Wolverton SE, eds. Comprehensive Dermatologic Drug Therapy, 1st edn. Philadelphia: WB Saunders Company, 2001: 402-422.
9. Farber EM, Nall L. Psoriasis: a stress-related disease. Cutis 1993; 51: 322-326.
10. Fortune DG, Richards HL, Main CJ, Griffiths CE. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998; 39: 196-201.
11. Picardi A, Abeni D. Stressful life events and skin diseases: disentangling evidence from myth. Psychother Psychosom 2001; 70: 118-136.
12. Gaston L, Lassonde M, Bernier-Buzzanga J, et al. Psoriasis and stress: a prospective study. J Am Acad Dermatol 1987; 17: 82-86.
13. Seville RH. Psoriasis and stress. Br J Dermatol 1977; 97: 297-302.
14. Fava GA, Perini GI, Santonastaso P, Fornasa CV. Life events and psychological distress in dermatologic disorders: psoriasis, chronic urticaria and fungal infections. Br J Med Psychol 1980; 53: 277-282.
15. Lyketsos GC, Stratigos J, Tawil G, et al. Hostile personality characteristics, dysthymic states and neurotic symptoms in urticaria, psoriasis and alopecia. Psychother Psychosom 1985; 44: 122-131.
16. Naldi L, Peli L, Parazzini F, Carrel CF. Family history of psoriasis, stressful life events, and recent infectious disease are risk factors for a first episode of acute guttate psoriasis: results of a case-control study. J Am Acad Dermatol 2001; 44: 433-438.
17. Gupta MA, Gupta AK, Kirkby S, et al. A psychocutaneous profile of psoriasis patients who are stress reactors: a study of 127 patients. Gen Hosp Psychiatry 1989; 11: 166-173.
18. Farber EM, Lonigan SW, Rein G. The role of psychoneuroimmunology in the pathogenesis of psoriasis. Cutis 1990; 46: 314-316.
19. Farber EM, Nickoloff BJ, Recht B, Fraki JE. Stress, symmetry, and psoriasis: possible role of neuropeptides. J Am Acad Dermatol 1986; 14: 305-311.
20. Seville RH. Psoriasis and stress, II. Br J Dermatol 1978; 98: 151-153.
21. Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 2000; 17: 174-178.
22. Russo PA, Ilchef R, Cooper AJ. Psychiatric morbidity in psoriasis: a review. Australas J Dermatol 2004; 45: 155-159.
23. Schmid-Ott G, Jaeger B, Boehm T, et al. Immunological effects of stress in psoriasis. Br J Dermatol 2009; 160: 782-785.
24. Berg M, Svensson M, Brandberg M, Nordlind K. Psoriasis and stress: a prospective study. J Eur Acad Dermatol Venereol 2008; 22: 670-674.
25. Polenghi MM, Molinari E, Gala C, et al. Experience with psoriasis in a psychosomatic dermatology clinic. Acta Derm Venereol (Stockh) 1994; 186: 65-66.
26. Nyfors A, Lemholt K. Psoriasis in children. A short review and a survey of 245 cases. Br J Dermatol 1975; 92: 437-442.
27. Al'Abadie MS, Kent GG, Gawkrodger DJ. The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 1994; 130: 199-203.
28. Mazzetti M, Mozzetta A, Soavi GC, et al. Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors. Acta Derm Venereol (Stockh) 1994; 186: 62-64.
29. Akay A, Pekcanlar A, Bozdag KE, et al. Assessment of depression in subjects with psoriasis vulgaris and lichen planus. J Eur Acad Dermatol Venereol 2002; 16: 347-352.
30. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Assessing illness-related stress in psoriasis: the psychometric properties of the Psoriasis Life Stress Inventory. J Psychosom Res 1997; 42: 467-475.
31. Ginsburg IH, Link BG. Feelings of stigmatization in patients with psoriasis. J Am Acad Dermatol 1989; 20: 53-63.
32. Gupta MA, Gupta AK. Quality of life of psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 241-242.
33. Devrimci-Ozguven H, Kundakci TN, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 2000; 14: 267-271.
34. Young M. The psychological and social burdens of psoriasis. Dermatol Nurs 2005; 17: 15-19.
35. Arnetz BB, Fjellner B, Eneroth P, Kallner A. Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 1985; 47: 528-541.
36. Reich A, Szepietowski JC, Winicka B, Pacan P. Does stress influence itching in psoriatic patients? Dermatol Psychosom 2003; 4: 151-155.
37. Reich A, Hrehorow E, Szepietowski JC. Pruritus is an important factor negatively influencing the wellbeing of psoriatic patients. Acta Derm Venereol 2010; 90: 257-263.
38. Fortune DG, Richards HL, Kirby B. Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 2003; 139: 752-756.
39. Fortune DG, Richards HL, Griffiths CE, Main CJ. Psychological stress, distress and disability in patients with psoriasis: consensus and variation in the contribution of illness perceptions, coping and alexithymia. Br J Clin Psychol 2002; 41: 157-174.
40. Gupta MA, Gupta AK, Watteel GN. Early onset (
41. Niemeier V, Nippesen M, Kupfer J, et al. Psychological factors associated with hand dermatoses: which subgroup needs additional psychological care? Br J Dermatol 2002; 146: 1031-1037.
42. Skevington SM, Bradshaw J, Hepplewhite A, et al. How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating the WHOQOL-100 Br J Dermatol 2006; 154: 680-691.
43. Feldman SR, Fleischer AB Jr, Reboussin DM, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997; 37: 564-569.
44. Kirkby B, Richards HL, Woo P, et al. Physical and psychological measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001; 45: 72-76.
45. Fortune DG, Main CJ, O'Sullivan TM, Griffiths CE. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol 1997; 137: 755-760.
46. Gupta MA, Gupta AK, Haberman HF. Psoriasis and psychiatry: an update. Gen Hosp Psychiatry 1987; 9: 157-166.
47. Matussek P, Agerer D, Seibt G. Aggression in depressives and psoriatics. Psychother Psychosom 1985; 43: 120-125.
48. Rubino IA, Sonnino A, Pezzarossa B, et al. Personality disorders and psychiatric symptoms in psoriasis. Psychol Rep 1995; 77: 547-553.
49. Vidoni D, Campiutti E, D'Aronco R, et al. Psoriasis and alexithymia. Acta Derm Venereol (Stockh) 1989; 146: 91-92.
50. Kimball AB, Jacobson C, Weiss S, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6: 383-392.
51. Schmitt JM, Ford DE. Role of depression in quality of life for patients with psoriasis. Dermatology 2007; 215: 17-27.
52. O'Leary CJ, Creamer D, Higgins E, Weinman J. Perceived stress, stress attributions and psychological distress in psoriasis. J Psychosom Res 2004; 57: 465-471.
53. Sampogna F, Tabolli S, Abeni D. The impact of changes in clinical severity on psychiatric morbidity in patients with psoriasis: a follow-up study. Br J Dermatol 2007; 157: 508-513.
54. Gupta MA, Schork NJ, Gupta AK, et al. Suicidal ideation in psoriasis. Int J Dermatol 1993; 32: 188-190.
55. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-850.
56. Morse RM, Perry HO, Hurt RD. Alcoholism and psoriasis. Alcohol Clin Exp Res 1985; 9: 396-399.
57. Mills CM, Srivastava RD, Harvey IM, et al. Smoking habits in psoriasis: a case control study. Br J Dermatol 1992; 127: 18-21.
58. Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002; 47: 512-518.
59. Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-284.
60. Jenner N, Campbell J, Plunkett A, Marks R. Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia. Australas J Dermatol 2002; 43: 255-261.
61. McHenry PM, Doherty VR. Psoriasis: an audit of patients' views on the disease and its treatment. Br J Dermatol 1992; 127: 13-17.
62. Yosipovitch G, Goon A, Wee J, et al. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000; 143: 969-973.
63. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-407.
64. Rapp SR, Exum ML, Reboussin DM, et al. The physical, psychological and social impact of psoriasis. J Health Psychol 1997; 2: 525-537.
65. Rapp SR, Feldman SR, Fleischer AB, et al. Health-related quality of life in psoriasis: a biopsychosocial model and measures. In: Rajagopalan R, Sherertz E, Anderson R, eds. Care and Management of Skin Diseases: Life Quality and Economic Impact. New York: Marcel Dekker, 1998: 125-146.
66. Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995; 75: 240-243.
67. Gupta MA, Gupta AK, Schork NJ, Ellis CN. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994; 56: 36-40.
68. Wahl AK, Gjengedal E, Hanestad BR. The bodily suffering of living with severe psoriasis: in-depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res 2002; 12: 250-261.
69. Zamirska A, Reich A, Berny-Moreno J, et al. Vulvar pruritus and burning sensation in women with psoriasis. Acta Derm Venereol 2008; 88: 132-135.
70. Koo J. Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment. Dermatol Clin 1996; 14: 485-496.
71. Pettey AA, Balkrishnan R, Rapp SR, et al. Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol 2003; 49: 271-275.
72. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-244.
73. Finlay AY, Kelly SE. Psoriasis: an index of disability. Clin Exp Dermatol 1987; 12: 8-11.
74. National Psoriasis Foundation Data. 2004; [online]. Available at:
75. de Jong EM, Seegers BA, Gulinck MK, et al. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1728 patients. Dermatology 1996; 193: 300-303.
76. Zachariae H, Zachariae R, Blomqvist K, et al. Quality of life and prevalence of arthritis reported by 5795 members of the Nordic Psoriasis Associations: data from the Nordic Quality of Life Study. Acta Derm Venereol 2002; 82: 108-113.
77. Lundberg L, Johannesson M, Silverdahl M, et al. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000; 80: 430-434.
78. Gladman DD, Rahman P. Psoriatic arthritis. In: Ruddy S, Harris ED, Sledge CB, et al., eds. Kelley's Textbook of Rheumatology, 6th edn. Philadelphia, PA: WB Saunders Company, 2001: 1071-1078.
79. Schmid-Ott G, Jaeger B, Kuensebeck HW, et al. Dimensions of stigmatization in patients with psoriasis in a 'Questionnaire on Experience with Skin Complaints'. Dermatology 1996; 193: 304-310.
80. Ginsburg IH, Link BG. Psychosocial consequences of rejection and stigma feelings in psoriasis patients. Int J Dermatol 1993; 32: 587-591.
81. Fried RG, Friedman S, Paradis C, et al. Trivial or terrible? The psychosocial impact of psoriasis. Int J Dermatol 1995; 34: 101-105.
82. Gupta MA, Gupta AK, Watteel GN. Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. Cutis 1998; 61: 339-342.
83. Krueger GG, Feldman SR, Camisa C, et al. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 2000; 43: 281-285.
84. Gupta MA, Gupta AK. Age and gender differences in the impact of psoriasis on quality of life. Int J Dermatol 1995; 34: 700-703.
85. Gupta MA, Gupta AK. Psoriasis and sex: a study of moderately to severely affected patients. Int J Dermatol 1997; 36: 259-262.
86. Ramsay B, O'Reagan M. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118: 195-201.
87. Fleischer AB Jr, Feldman SR, Bradham DD. Office-based physician services provided by dermatologists in the United States in 1990. J Invest Dermatol 1994; 102: 93-97.
88. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease. J Am Acad Dermatol 2006; 54: 420-426.
89. Harth W, Hillert A, Hermes B, et al. Suicidal behavior in dermatology. Hautarzt 2008; 59: 289-296.
90. Bouguéon K, Misery L. Depression and psoriasis. Ann Dermatol Venereol 2008; 135: 254-258.
91. Van Voorhees AS, Fried R. Depression and quality of life in psoriasis. Postgrad Med 2009; 121: 154-161.
92. Hardy GE, Cotterill JA. A study of depression and obsessionality in dysmorphophobic and psoriatic patients. Br J Psychiatry 1982; 140: 19-22.
93. Pacan P, Szepietowski JC, Kiejna A. Stressful life events and depression in patients suffering from psoriasis vulgaris. Dermatol Psychosom 2003; 4: 142-145.
94. Henderson CA, Highet AS. Depression induced by etretinate. BMJ 1989; 298: 964.
95. Scharloo M, Kaptein AA, Weinman J, et al. Patients' illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 2000; 142: 899-907.
96. Farber EM, Nall L. Psoriasis and alcoholism. Cutis 1994; 53: 21-27.
97. Wolf R, Wolf D, Ruocco V. Alcohol intake and psoriasis. Clin Dermatol 1999; 17: 423-430.
98. Higgins EM, du Vivier AW. Alcohol abuse and treatment resistance in skin disease [letter]. J Am Acad Dermatol 1994; 30: 1048.
99. Higgins EM, du Vivier AW. Cutaneous disease and alcohol misuse. Br Med Bull 1994; 50: 85-98.
100. Higgins EM, du Vivier AW. Alcohol and the skin. Alcohol Alcohol 1992; 27: 595-602.
101. Gupta MA, Schork NJ, Gupta AK, Ellis CN. Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol 1993; 28: 730-732.
102. Vincenti GE, Blunden SM. Psoriasis and alcohol abuse. J R Army Med Corps 1987; 133: 77-78.
103. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 1999; 135: 1490-1493.